Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05477082 · ClinicalTrials.gov registry record

Blood Biomarkers in Pediatric Kidney Transplant Recipients

A clinical trial of Rejection of Kidney Allograft, sponsored by University of Minnesota.

Active
Registry status
27
Enrollment target
1
Study location

NCT05477082 is a study of Rejection of Kidney Allograft that is active but no longer recruiting, run by University of Minnesota. The registered enrollment target is 27 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05477082, a study of Rejection of Kidney Allograft, is active but no longer recruiting, sponsored by University of Minnesota.

ACTIVE NOT RECRUITING
Registry status
27 participants
Enrollment target
1
Study location

Study Summary

The objective of the proposed study is to assess whether a blood biomarker can be used to monitor the response to rejection treatment in pediatric kidney transplant recipients with biopsy-proven acute cellular or antibody mediated rejection. The study hypothesizes that blood gene expression profile and donor-derived cell-free DNA biomarkers (omnigraf) can be used to predict acute rejection and monitor its response to treatment.

Interventions

  • OTHER Observational group

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2023-08-21
Est. Completion 2026-11-01

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT05477082

The ClinicalTrials.gov registry entry for NCT05477082 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rejection of Kidney Allograft appearing as the primary indexed condition, and to 1 intervention - of which Observational group is the first listed.

NCT05477082 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT05477082 about?

NCT05477082 is a clinical study titled "Blood Biomarkers in Pediatric Kidney Transplant Recipients". The objective of the proposed study is to assess whether a blood biomarker can be used to monitor the response to rejection treatment in pediatric kidney transplant recipients with biopsy-proven acute cellular or antibody mediated rejection. The study hypothesizes that blood gene expression profile ...

What is the current status of trial NCT05477082?

This trial is currently active not recruiting. The enrollment target is 27 participants. The study started on 2023-08-21. Estimated completion is 2026-11-01.

What conditions does trial NCT05477082 study?

This clinical trial studies the following conditions: Rejection of Kidney Allograft.

What interventions are being tested in trial NCT05477082?

The interventions under investigation include: Observational group (OTHER).

Who is sponsoring clinical trial NCT05477082?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05477082 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.